Literature DB >> 28027928

Dengue virus non-structural Protein-1 expression and associated risk factors among febrile Patients attending University of Abuja Teaching Hospital, Nigeria.

Idris Abdullahi Nasir1, Olubunmi Olajide Agbede2, Amos Dangana3, Marycelin Baba4, Abubakar Shehu Haruna5.   

Abstract

BACKGROUND: Dengue is a mosquito-borne and neglected tropical viral disease that has been reported to be hyper-endemic in Nigeria. However, this is the first dengue study in Abuja.
OBJECTIVE: This hospital-based cross-sectional study investigated the prevalence of Dengue virus (DENV) non-structural protein-1 (NS1) antigenaemia, anti-Dengue virus IgG and their associated risk factors among febrile patients attending the University of Abuja Teaching Hospital (UATH), Nigeria.
MATERIALS AND METHODS: From May to August 2016, blood samples were individually collected from 171 consented participants. These samples were analyzed using DENV NS1 and anti-DENV IgG Enzyme Linked Immunosorbent Assay (ELISA) kits. Well-structured questionnaires was used to collect sociodemographic variables of participants.
RESULTS: Out of the 171 participants, the prevalence of Dengue virus NS1 antigenaemia and IgG seropositivity were 8.8% and 43.3%, respectively. Three (1.8%) of the patients were NS1 (+) IgG (-), 12 (7.0%) had NS1 (+) IgG (+), 62 (36.3%) were NS1 (-) IgG (+), while 97 (56.7%) of the remaining patients were NS1 (-) IgG (-). There was statistical association between DENV NS1 antigenaemia with age of patients (p=0.034), residence in proximity to waste dumpsites (p<0.0001) but not with occupation of patients (p=0.166), use of indoor insecticide sprays (p=0.4910) and presence of household artificial water containers (p=0.3650). There was statistical association between the prevalence of anti-Dengue virus IgG with occupation (p=0.0034) and education level of patients (p<0.001). However, there was no statistical association between the prevalence of anti-Dengue virus IgG with gender (p=0.4060) and residential area of patients (p=0.3896).
CONCLUSION: Findings from this study revealed that DENV infection is one of the etiological agents of acute febrile illnesses in Abuja. It's recommended that Dengue testing be considered during differential diagnosis of febrile patients.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antigenaemia; Dengue; Differential diagnosis; Risk factors

Mesh:

Substances:

Year:  2016        PMID: 28027928     DOI: 10.1016/j.virusres.2016.12.011

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  4 in total

1.  Socioeconomic risk markers of arthropod-borne virus (arbovirus) infections: a systematic literature review and meta-analysis.

Authors:  Grace M Power; Aisling M Vaughan; Luxi Qiao; Nuria Sanchez Clemente; Julia M Pescarini; Enny S Paixão; Ludmila Lobkowicz; Amber I Raja; André Portela Souza; Mauricio Lima Barreto; Elizabeth B Brickley
Journal:  BMJ Glob Health       Date:  2022-04

2.  The Seroprevalence and Hidden Burden of Chikungunya Endemicity and Malaria Mono- and Coinfection in Nigeria.

Authors:  Peter Asaga Mac; Philomena E Airiohuodion; Andrew B Yako; James K Makpo; Axel Kroeger
Journal:  Int J Environ Res Public Health       Date:  2022-07-22       Impact factor: 4.614

3.  Dengue Virus is Hyperendemic in Nigeria from 2009 to 2020: A Contemporary Systematic Review.

Authors:  Anthony Uchenna Emeribe; Idris Nasir Abdullahi; Idongesit Kokoabasi Isong; Anthony Ogbonna Emeribe; Justin Onyebuchi Nwofe; Buhari Isa Shuaib; Abubakar Muhammad Gwarzo; Yahaya Usman; Madjid Sadi; Chikodi Modesta Umeozuru; Amos Dangana; Bibiana Nonye Egenti; Mala Alhaji Baba Mallam; Abigail Uchenna Emelonye; Maijiddah Saidu Aminu; Hadiza Yahaya; Silifat Oyewusi
Journal:  Infect Chemother       Date:  2021-06

Review 4.  Dengue Virus Infection and Associated Risk Factors in Africa: A Systematic Review and Meta-Analysis.

Authors:  Gaspary O Mwanyika; Leonard E G Mboera; Sima Rugarabamu; Baraka Ngingo; Calvin Sindato; Julius J Lutwama; Janusz T Paweska; Gerald Misinzo
Journal:  Viruses       Date:  2021-03-24       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.